menu
    • menu

    Company profile for G1 Therapeutics, Inc

    NEW Drugs in Dev: 7
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our mission is to discover, develop and deliver innovative therapies that improve the lives of those affected by cancer. Led by a team with a deep understanding of the biology of cancer and extensive drug discovery, development and commercialization experience, we are rapidly advancing three clinical-stage therapies for people living with cancer. Trilaciclib is a first-in-class investigational therapy designed to improve out...
    Our mission is to discover, develop and deliver innovative therapies that improve the lives of those affected by cancer. Led by a team with a deep understanding of the biology of cancer and extensive drug discovery, development and commercialization experience, we are rapidly advancing three clinical-stage therapies for people living with cancer. Trilaciclib is a first-in-class investigational therapy designed to improve outcomes for people with cancer who are treated with chemotherapy.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    G1 Therapeutics, IncUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    700 Park Offices Drive Suite 200 Research Triangle Park, NC 27709
    Telephone
    Telephone
    919-213-9835
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.g1therapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/g1-therapeutics-inc-/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BioProcess International US West

    Not Confirmed

    envelop Contact Supplier

    BioProcess International US West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pharmacosmos And G1 Therapeutics Close Tender Offer
    Pharmacosmos And G1 Therapeutics Close Tender Offer

    18 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/18/2948213/0/en/Pharmacosmos-Group-and-G1-Therapeutics-Announce-Successful-Closing-of-Tender-Offer.html

    GLOBENEWSWIRE
    18 Sep 2024
    Share Share
    Pharmacosmos And G1 Therapeutics Announce HSR Waiting Period End
    Pharmacosmos And G1 Therapeutics Announce HSR Waiting Period End

    05 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/05/2941161/0/en/Pharmacosmos-Group-and-G1-Therapeutics-Announce-Expiration-of-Hart-Scott-Rodino-Waiting-Period.html

    GLOBENEWSWIRE
    05 Sep 2024
    Share Share
    Pharmacosmos Picks Up G1 Therapeutics, FDA-Approved Drug Cosela In Worth $405M
    Pharmacosmos Picks Up G1 Therapeutics, FDA-Approved Drug Cosela In Worth $405M

    08 Aug 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/pharmacosmos-picks-g1-therapeutics-and-its-cosela-merger-worth-405m

    FIERCE PHARMA
    08 Aug 2024
    Share Share
    G1 Therapeutics Provides Q2 2024 Results And Operational Highlights
    G1 Therapeutics Provides Q2 2024 Results And Operational Highlights

    08 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/08/2926725/0/en/G1-Therapeutics-Provides-Second-Quarter-2024-Financial-Results-and-Operational-Highlights.html

    GLOBENEWSWIRE
    08 Aug 2024
    Share Share
    G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    01 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/01/2923330/0/en/G1-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    01 Aug 2024
    Share Share
    G1 Therapeutics To Release Q2 2024 Results On August 8
    G1 Therapeutics To Release Q2 2024 Results On August 8

    25 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/25/2918990/0/en/G1-Therapeutics-to-Release-Second-Quarter-2024-Financial-Results-and-Provide-Business-Update-on-August-8-2024.html

    GLOBENEWSWIRE
    25 Jul 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search